Abstract
Introduction
Risk assessment for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) remains complex. The goal of this study was to assess electrocardiogram (ECG)-derived risk factors on SCD in a large HCM population Methods: Retrospective review of adults with HCM evaluated at Mayo Clinic, Rochester, MN from 1 December 2002 to 31 December 2012 was performed. Data inclusive of ECG and 24-hour ambulatory Holter monitor were assessed. SCD events were documented by ventricular fibrillation (VF) noted on implantable cardioverter defibrillator (ICD), or appropriate VT or VF-terminating ICD shock.Results
Overall, 1615 patients (mean age 53.7 ± 15.2 years; 943 males, 58.4%) were assessed, with mean follow-up 2.46 years and 110 SCD events. Via logistic regression (n = 820), the odds of SCD increased with increasing number of conventional risk factors. With one risk factor the OR was 4.88 (p < .0001; CI 2.22-10.74), two risk factors the OR was 6.922 (p < .0001; CI 2.94-16.28) and three or more risk factors, the OR was 13.997 (p < .0001; CI 5.649-34.68). Adding QTc > 450 to this logistic regression model had OR 1.722 (p = .04, CI 1.01-2.937) to predict SCD. QTc ≥ 450 was a significant predictor for death (HR 1.88, p = .021, CI 1.10-3.20). There was no correlation between sinus bradycardia, sinus tachycardia, first degree AV block, atrial fibrillation, left bundle branch block, right bundle branch block, premature atrial complexes, premature ventricular complexes, supraventricular tachycardia, PR interval, QRS interval and SCD.Conclusions
Prolonged QTc was a risk factor for SCD and death even when controlling for typical risk factors.References
Articles referenced by this article (14)
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.
Circulation, (4):785-789 1995
MED: 7641357
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation, (24):2761-2796 2011
MED: 22068435
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
J Am Coll Cardiol, (21):2362-2371 2015
MED: 26542657
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
JAMA, (7):650-655 1999
MED: 10029128
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol, (25):2703-2738 2011
MED: 22075468
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
Eur Heart J, (30):2010-2020 2013
MED: 24126876
Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy.
Am J Cardiol, (5):757-764 2015
MED: 26183790
Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort.
Am J Cardiol, (1):114-5, A9 2001
MED: 11137847
Is QT dispersion associated with sudden cardiac death in patients with hypertrophic cardiomyopathy?
Ann Noninvasive Electrocardiol, (3):209-215 2001
MED: 11466139
Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy.
Eur Heart J, (9):1114-1120 2011
MED: 21345853
Show 4 more references (10 of 14)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1080/00015385.2018.1440905
Article citations
Sport-related differences in QT dispersion and echocardiographic parameters in male athletes.
Sci Rep, 13(1):6770, 25 Apr 2023
Cited by: 1 article | PMID: 37185606 | PMCID: PMC10130053
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.
Eur J Prev Cardiol, 29(4):645-653, 01 Mar 2022
Cited by: 10 articles | PMID: 33772274 | PMCID: PMC8967480
Prevalence and Risk Factors of QTc Prolongation During Pregnancy.
Front Cardiovasc Med, 8:819901, 24 Jan 2022
Cited by: 2 articles | PMID: 35141298 | PMCID: PMC8818739
Deciphering hypertrophic cardiomyopathy with electrocardiography.
Heart Fail Rev, 27(4):1313-1323, 21 Jul 2021
Cited by: 1 article | PMID: 34286451
Review
QT Interval Dynamics and Cardiovascular Outcomes: A Cohort Study in an Integrated Health Care Delivery System.
J Am Heart Assoc, 10(19):e018513, 28 Sep 2021
Cited by: 6 articles | PMID: 34581201 | PMCID: PMC8649135
Go to all (11) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy.
J Cardiovasc Electrophysiol, 26(12):1346-1351, 13 Oct 2015
Cited by: 2 articles | PMID: 26332198
QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
J Cardiovasc Electrophysiol, 26(5):547-555, 27 Mar 2015
Cited by: 31 articles | PMID: 25648421
Prognostic value of electrocardiographic time intervals and QT rate dependence in hypertrophic cardiomyopathy.
J Electrocardiol, 51(6):1077-1083, 12 Sep 2018
Cited by: 5 articles | PMID: 30497734
Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Eur J Prev Cardiol, 24(11):1220-1230, 09 May 2017
Cited by: 37 articles | PMID: 28482693
Review
Funding
Funders who supported this work.